Alfieri Michael, Principal Financial Officer of Aldeyra Therapeutics ($ALDX), made one open market purchase of common shares in the last 365 days, totaling $13,250. His most recent buy occurred on August 13, 2025. This ranks 4,113th among 4,983 insiders in our database by purchase amount, below the average of $1.5 million across 3.29 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | Aldeyra Therapeutics, Inc. | $ALDX | Alfieri Michael | Principal Financial Officer | P | Common Stock | 5000 | $1.42 | 7,500.0000 | 60,162,773 | 200.00% | 0.01% |
| Aug. 13, 2025 | Aldeyra Therapeutics, Inc. | $ALDX | Alfieri Michael | Principal Financial Officer | P | Common Stock | 2500 | $5.30 | 2,500.0000 | 59,708,654 | 9999.99% | 0.00% |